Search for a mental health provider in your area who may help you manage your bipolar I†
†By clicking through to search for healthcare providers, you acknowledge and agree with the Terms and Conditions.
PLEASE NOTE: While we update our directory regularly, this list may not have current provider information. This is an AbbVie Inc.-compiled list of prescribers known to have prescribed therapies including VRAYLAR in the past 12 months. The results shown may not be inclusive of all providers who may have experience with therapies such as VRAYLAR in your area. Please see the Terms and Conditions for additional details.
†By clicking through to search for healthcare providers, you acknowledge and agree with the Terms and Conditions.
PLEASE NOTE: While we update our directory regularly, this list may not have current provider information. This is an AbbVie Inc.-compiled list of prescribers known to have prescribed therapies including VRAYLAR in the past 12 months. The results shown may not be inclusive of all providers who may have experience with therapies such as VRAYLAR in your area. Please see the Terms and Conditions for additional details.
Use “My Mood Tracker” to record your symptoms each day and help your healthcare provider spot warning signs of bipolar I disorder.
You’re greater than your bipolar I disorder symptoms. Watch our TV ad and ask your doctor if VRAYLAR may be able to help you manage your bipolar I.
INDICATIONS AND USAGE
VRAYLAR is approved in adults to treat depressive episodes that happen with bipolar I disorder (bipolar depression) and for the short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder.
IMPORTANT SAFETY INFORMATION
Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis.
VRAYLAR and antidepressants may increase suicidal thoughts or actions in some children and young adults especially within the first few months of treatment or when the dose is changed. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when VRAYLAR or the antidepressant is started or when the dose is changed. Report any change in these symptoms immediately to the doctor.
VRAYLAR may cause serious side effects, including:
Who should not take VRAYLAR?
Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat).
What should I tell my healthcare provider before taking VRAYLAR?
Tell your healthcare provider about any medical conditions and if you:
Tell your healthcare provider about all medicines that you take, including prescriptions, over-the-counter medicines, vitamins, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works. Do not start or stop any medicines while taking VRAYLAR without talking to your healthcare provider.
What are the most common side effects of VRAYLAR?
The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness.
These are not all the possible side effects of VRAYLAR.
INDICATIONS AND USAGE
VRAYLAR is a prescription medicine used in adults:
Please see the full Prescribing Information, including Boxed Warnings, and Medication Guide.
US-VRAA-230239
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
*Depending on insurance coverage, eligible patients may pay as little as $5 for each of up to twelve (12) prescription fills. In such instances, eligible patients who have not previously registered for a VRAYLAR® (cariprazine) savings card may pay as little as $0 for their first two (2) 30-day fills. Eligible patients whose insurer does not cover VRAYLAR® (cariprazine) or where coverage restrictions have not been satisfied may pay as little as $75 per 30-day supply for each of up to twelve (12) prescription fills. Check with your pharmacist for your copay discounts. Maximum savings limit applies; patient out-of-pocket expenses may vary. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state health care programs. Please see https://allergansavingscard.com/vraylar for Program Terms, Conditions, and Eligibility Criteria.
US-VRAA-220054
US-VRAA-220054
US-VRAA-220054
US-VRAA-220054